These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 19461083

  • 1. Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions.
    Gambichler T, Grothe S, Rotterdam S, Altmeyer P, Kreuter A.
    Am J Clin Pathol; 2009 Jun; 131(6):782-7. PubMed ID: 19461083
    [Abstract] [Full Text] [Related]

  • 2. Minichromosome maintenance proteins are useful adjuncts to differentiate between benign and malignant melanocytic skin lesions.
    Gambichler T, Shtern M, Rotterdam S, Bechara FG, Stücker M, Altmeyer P, Kreuter A.
    J Am Acad Dermatol; 2009 May; 60(5):808-13. PubMed ID: 19389522
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions.
    Gambichler T, Rotterdam S, Radkowski K, Altmeyer P, Kreuter A.
    Am J Clin Pathol; 2009 May; 131(5):710-4. PubMed ID: 19369632
    [Abstract] [Full Text] [Related]

  • 4. Versican overexpression in cutaneous malignant melanoma.
    Gambichler T, Kreuter A, Grothe S, Altmeyer P, Brockmeyer NH, Rotterdam S.
    Eur J Med Res; 2008 Nov 24; 13(11):500-4. PubMed ID: 19073385
    [Abstract] [Full Text] [Related]

  • 5. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
    Khalifeh I, Taraif S, Reed JA, Lazar AF, Diwan AH, Prieto VG.
    Am J Surg Pathol; 2007 Jul 24; 31(7):1130-6. PubMed ID: 17592281
    [Abstract] [Full Text] [Related]

  • 6. Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.
    Einspahr JG, Thomas TL, Saboda K, Nickolof BJ, Warneke J, Curiel-Lewandrowski C, Ranger-Moore J, Duckett L, Bangert J, Fruehauf JP, Alberts DS.
    Cancer; 2007 Dec 01; 110(11):2519-27. PubMed ID: 17932890
    [Abstract] [Full Text] [Related]

  • 7. Nucleolin protein expression in cutaneous melanocytic lesions.
    Mourmouras V, Cevenini G, Cosci E, Epistolato MC, Biagioli M, Barbagli L, Luzi P, Mannucci S, Miracco C.
    J Cutan Pathol; 2009 Jun 01; 36(6):637-46. PubMed ID: 19515042
    [Abstract] [Full Text] [Related]

  • 8. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms.
    Cohn ML, Goncharuk VN, Diwan AH, Zhang PS, Shen SS, Prieto VG.
    J Cutan Pathol; 2005 Sep 01; 32(8):533-6. PubMed ID: 16115050
    [Abstract] [Full Text] [Related]

  • 9. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR, El-Zammar O.
    Am J Dermatopathol; 2008 Apr 01; 30(2):117-22. PubMed ID: 18360113
    [Abstract] [Full Text] [Related]

  • 10. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS, Shakhtour B, Shyr Y.
    J Am Acad Dermatol; 2008 May 01; 58(5):750-4. PubMed ID: 18249467
    [Abstract] [Full Text] [Related]

  • 11. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
    Clarke LE, Fountaine TJ, Hennessy J, Bruggeman RD, Clarke JT, Mauger DT, Helm KF.
    J Cutan Pathol; 2009 Apr 01; 36(4):433-8. PubMed ID: 19278428
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
    Khatib N, Pe'er J, Ortenberg R, Schachter J, Frenkel S, Markel G, Amer R.
    Invest Ophthalmol Vis Sci; 2011 Dec 09; 52(13):9368-72. PubMed ID: 22039239
    [Abstract] [Full Text] [Related]

  • 15. Cyclin D1 expression in melanocytic lesions of the skin.
    Ramirez JA, Guitart J, Rao MS, Diaz LK.
    Ann Diagn Pathol; 2005 Aug 09; 9(4):185-8. PubMed ID: 16084449
    [Abstract] [Full Text] [Related]

  • 16. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
    Massi D, Naldini A, Ardinghi C, Carraro F, Franchi A, Paglierani M, Tarantini F, Ketabchi S, Cirino G, Hollenberg MD, Geppetti P, Santucci M.
    Hum Pathol; 2005 Jun 09; 36(6):676-85. PubMed ID: 16021575
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. TSLC1 expression discriminates cutaneous melanomas from dysplastic nevi.
    You Y, Wang SH, Zhang JF, Zheng SY.
    Melanoma Res; 2012 Dec 09; 22(6):430-5. PubMed ID: 23047161
    [Abstract] [Full Text] [Related]

  • 19. bcl-2 protein expression in melanocytic neoplasms of the skin.
    Ramsay JA, From L, Kahn HJ.
    Mod Pathol; 1995 Feb 09; 8(2):150-4. PubMed ID: 7777475
    [Abstract] [Full Text] [Related]

  • 20. Markers of melanocytic tumour progression.
    Ruiter DJ, van Muijen GN.
    J Pathol; 1998 Dec 09; 186(4):340-2. PubMed ID: 10209480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.